ABSTRACT 17␣-Ethynylestradiol (EE), a major constituent of many oral contraceptives, inactivated the testosterone 6␤-hydroxylation activity of purified P450 3A4 reconstituted with phospholipid and NADPH-cytochrome P450 reductase in a mechanismbased manner. The inactivation of P450 3A4 followed pseudo first order kinetics and was dependent on NADPH. The values for the K I and k inact were 18 M and 0.04 min Ϫ1 , respectively, and the t 1/2 was 16 min. Incubation of 50 M EE with P450 3A4 at 37°C for 30 min resulted in a 67% loss of testosterone 6␤-hydroxylation activity accompanied by a 35% loss of the spectral absorbance of the native protein at 415 nm and a 70% loss of the spectrally detectable P450-CO complex. The inactivation of P450 3A4 by EE was irreversible. Testosterone, an alternate substrate, was able to protect P450 3A4 from EEdependent inactivation. The partition ratio was ϳ50. (HPLC) analysis demonstrated that the inactivation resulting from EE metabolism led to the destruction of approximately half the heme with the concomitant generation of modified heme and EE-labeled heme fragments and produced covalently radiolabeled P450 3A4 apoprotein. Electrospray mass spectrometry demonstrated that the fraction corresponding to the major radiolabeled product of EE metabolism has a mass (M Ϫ H) Ϫ of 479 Da. HPLC and gas chromatography-mass spectometry analyses revealed that EE metabolism by P450 3A4 generated one major metabolite, 2-hydroxyethynylestradiol, and at least three additional metabolites. In conclusion, our results demonstrate that EE is an effective mechanism-based inactivator of P450 3A4 and that the mechanism of inactivation involves not only heme destruction, but also the irreversible modification of the apoprotein at the active site.
[ 3 H]EE was irreversibly bound to the P450 3A4 apoprotein. After extensive dialysis of the [ 3 H]EE inactivated samples, high-pressure liquid chromatography (HPLC) analysis demonstrated that the inactivation resulting from EE metabolism led to the destruction of approximately half the heme with the concomitant generation of modified heme and EE-labeled heme fragments and produced covalently radiolabeled P450 3A4 apoprotein. Electrospray mass spectrometry demonstrated that the fraction corresponding to the major radiolabeled product of EE metabolism has a mass (M Ϫ H) Ϫ of 479 Da. HPLC and gas chromatography-mass spectometry analyses revealed that EE metabolism by P450 3A4 generated one major metabolite, 2-hydroxyethynylestradiol, and at least three additional metabolites. In conclusion, our results demonstrate that EE is an effective mechanism-based inactivator of P450 3A4 and that the mechanism of inactivation involves not only heme destruction, but also the irreversible modification of the apoprotein at the active site.
The cytochromes P450 comprise a large family of microsomal heme-containing monooxygenases that are involved in the metabolism of a wide variety of xenobiotics including drugs, pesticides, environmental pollutants, and carcinogens, as well as endogenous compounds such as steroids, retinoids, and fatty acids. The catalytic mechanism appears to be common to all P450s and involves a two-electron reduction of molecular oxygen to form a reactive oxygen species and water (Porter and Coon, 1991; Rendic and Di Carlo, 1997) .
17␣-Ethynylestradiol (EE), the major estrogenic component of many oral contraceptives, can be metabolized by P450 enzymes in various animal species and humans (Bolt, 1979) . Drugs, hormones, insecticide synergists, carcinogens, or dietary constituents that influence the expression and activity of various P450s can modulate the efficacy and side effects of EE (Bolt and Kassel, 1976; Guengerich, 1990a,b; He et al., 1998b) . Studies using microsomes from phenobarbital-induced rats have demonstrated that the metabolism of EE results in a decrease in the cytochrome P450 content determined by the reduced CO difference spectrum and leads to the formation of the green pigments obtained from N-alkylated porphyrins (White, 1978; Ortiz de Montellano et al., 1979; Blakey and White, 1986) . In addition, the mechanismbased inactivation of human liver microsomal P450s by EE with the loss of the P450-CO spectrum during incubation with NADPH has been shown (Guengerich, 1988) . The EEmediated inactivation in both rat and human liver microsomal P450s was postulated to be due to the metabolism of the acetylenic moiety of EE and the ensuing modification of the heme moiety of the P450s. However, the details of the kinetic parameters for the inactivation and modification of the apoprotein by an EE-derived metabolite were not reported (Guengerich, 1990a) .
Cytochrome P450 3A4 (3A4) is the most abundant P450 isoform in human liver, has very broad substrate specificity, and is believed to be responsible for the metabolism of more than 60% of all clinically relevant drugs including contraceptive steroids (Guengerich, 1995) . The substrates for 3A4 can be inactivators as well as inducers; thus during therapy with multiple drugs, drug-drug interactions may result in problems of clinical significance. 3A4 has been shown to be the principal catalyst involved in the oxidation of EE. In a series of human liver microsomes, the rate of the 2-hydroxylation of EE correlated well with both the rate of nifedipine oxidation and immunochemically determined 3A4 (Guengerich, 1988) . We have used purified 3A4 reconstituted with phospholipids, NADPH-cytochrome P450 reductase (reductase), and catalase to characterize the EE-dependent inactivation of the testosterone 6␤-hydroxylase activity of 3A4. The following parameters were measured: the values for the concentration of EE required to give the half-maximal rate of inactivation (K I ); the maximal rate constant of inactivation at saturating concentrations of EE (k inact ); the time required for half the P450 to be inactivated at saturating concentrations of EE (t 1/2 ); the partition ratio; the UV-visible spectrum; the reduced CO difference spectrum; the effect of an alternate substrate on the loss of catalytic activity; and the stoichiometry and specificity of EE binding.
The reactive intermediates of acetylenic compounds formed by several isoforms of P450 have been known to alkylate the prosthetic heme group as well as to bind covalently to the protein (Ortiz de Montellano and Correia, 1995) . Studies with P450 2B1 demonstrated that 2-ethylnylnaphthalene predominantly inactivates P450 2B1 through modification of the apoprotein, whereas phenylacetylene inactivates P450 2B1 via N-alkylation of heme (Ortiz de Montellano and Komives, 1985; Roberts et al., 1993) . In this report, radiolabeled EE was employed in studies using SDS-PAGE and reversed-phase HPLC analysis to investigate the targets for EE-mediated 3A4 modification. To elucidate the identity of the reactive metabolite(s) involved in the heme and apoprotein modification and the mechanism(s) for inactivation by EE, the metabolites of EE were resolved by HPLC and further characterized by GC-MS.
Materials and Methods
Chemicals. Cholic acid, catalase, NADPH, glutathione, testosterone, 6␣-hydroxytestosterone, 6␤-hydroxytestosterone, estradiol, estrone, and EE were purchased from Sigma-Aldrich (St. Louis, MO). 2␣-, 4␣-, and 16␣-hydroxyestradiol were obtained from Steraloids Inc. (Newport, RI). Synthesis of 17␣-carboxyestradiol was described in the previous study (Kent et al., 2002) . 2-Hydroxyethynylestradiol (2-OH-EE) was a generous gift from Dr. William Slikker (Department of Health and Human Services, Food and Drug Administration, Jefferson, AR). 17␣- [6,7- 3 H]Ethynylestradiol (46.2 Ci/mmol) with radiochemical purity of 99% was obtained from Amersham Biosciences (Piscataway, NJ). All other chemicals and solvents were of the highest purity from commercial sources.
Purification of Enzyme. Both 3A4 and reductase were expressed in Escherichia coli and purified to homogeneity as described (Hanna et al., 1998; He et al., 1999) .
Enzyme Assay and Inactivation. For the primary reaction mixture, 0.5 nmol of 3A4 was reconstituted with 60 g of a mixture (1:1:1) of L-␣-dilauroyl-phosphocholine, L-␣-dioleyl-sn-glycero-3-phosphocholine, and L-␣-phosphatidylserine, 200 g of recrystallized sodium cholate, 1 nmol of reductase, 100 U of catalase, and 2 mM glutathione in 1 ml of assay buffer containing 50 mM HEPES (pH 7.5), 20% glycerol, 30 mM MgCl 2 , and 0.5 mM EDTA. In studies of the time-and concentration-dependent inactivation by EE, the reactions were initiated by the addition of 1 mM NADPH to the primary reaction mixture, or the same volume of water was added as a control and the reaction mixtures were incubated at 37°C for the times indicated. The secondary reactions were started by transferring 50 l of the primary reaction mixtures to 950 l of assay buffer containing 200 M testosterone and 200 M NADPH. Incubations were carried out at 37°C for 20 min and then the reactions were terminated by the addition of 2 ml of ethyl acetate. The internal standard, 6␣-hydroxytestosterone, was added and the products were extracted into the organic phase. The major metabolite, 6␤-hydroxytestosterone, and the internal standard were quantified after separation by HPLC as described previously (He et al., 1999) . The activity of 3A4 in the reconstituted system was 14.8 Ϯ 1.2 nmol of 6␤-hydroxytestosterone formed per minute per nanomole of P450.
Spectral Analysis. After incubating the primary reaction mixtures with 50 M EE in the presence (inactivated sample) or absence of NADPH (control sample), the absolute spectra and reduced CO difference spectra of 0.25 nmol of 3A4 were determined by scanning from 400 to 600 nm on an SLM-AMINCO 3000 spectrophotometer (Omura and Sato, 1964) . In addition, 50 l aliquots of the reaction mixtures were removed for the determination of the testosterone 6␤-hydroxylation activity. To test the irreversibility of inactivation, the control and inactivated samples were dialyzed overnight at 4°C against 1 liter of assay buffer and then reanalyzed both for enzymatic activity and reduced CO difference spectra.
Substrate Protection. The inactivation of 3A4 by EE in the presence or absence of substrate was investigated by adding an 8-and 16-fold molar excess of testosterone over EE to the primary reaction mixture. At the end of the incubation time, aliquots were removed for the determination of 3A4 activity remaining as described above.
Partition Ratio. EE at concentrations of 1 to 125 M was added to the primary reaction mixtures containing 0.5 M 3A4. After adding 1 mM NADPH, the reaction mixtures were incubated for 1 h to allow the inactivation to reach completion. Aliquots were removed and assayed for catalytic activity remaining as previously described (Silverman, 1996) .
Stoichiometry and Specificity of Binding. Following incubation with 50 M radiolabeled EE in the primary reaction mixtures for 1 h, 1-ml aliquots of the control (ϪNADPH) and inactivated (ϩNADPH) samples were mixed with 10 mg of bovine serum albumin and precipitated by adding a 5-fold volume of a 5% solution of sulfuric acid in methanol according to the method described by Ortiz de Montellano and coworkers (Ortiz de Montellano, 1991; Chan et al., 1993) . The precipitates were collected by centrifugation, and the resulting pellets were washed five times with the same solvent until the radioactivity in the supernatant was essentially at background level. The final pellets were dissolved in 1 N NaOH, incubated at 60°C for 1 h and neutralized with HCl prior to liquid scintillation counting using Econo-Safe counting cocktail (Research Products International Corp., Mount Prospect, IL). For SDS-PAGE analysis, two sets of control and inactivated samples were resolved on 8% polyacrylamide gels. After staining with Coomassie Blue, one set of gels was photographed, and the protein bands were excised and dissolved in H 2 O 2 at 60°C for 3 h followed by liquid scintillation counting to determine the protein-associated radioactivity. The other set of gels was treated with universal autoradiograph enhancer (PerkinElmer Life Sciences, Boston, MA) and then dried on 3-mm chromatography paper. The dried gels were exposed to Kodak BioMax MS film (Eastman Kodak, Rochester, NY) at Ϫ80°C for 2 weeks before developing.
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org Downloaded from HPLC Analysis. The control (ϪNADPH) and inactivated (ϩNADPH) samples that had been incubated with [
3 H]EE were dialyzed extensively to remove noncovalently bound radioactivity. The dialyzed samples were analyzed by HPLC on a C4 protein and peptide column (4.6 ϫ 250 mm, 300 Å; VYDAC, Hesperia, CA) with a solvent system consisting of solvent A (0.1% trifluoroacetic acid in water) and solvent B (95% acetonitrile and 0.1% trifluoroacetic acid) using a linear gradient from 35% B to 80% B over 45 min with a flow rate of 1 ml/min. The eluate was monitored at 220 nm for protein, at 280 nm for EE and protein, and at 405 nm for heme. Fractions were collected and the radioactivity was determined by liquid scintillation counting. Additionally, we used 10% trifluoroacetic acid/butanone to extract noncovalently bound heme or other components from proteins in the radiolabeled control and inactivated samples. The organic phases were dried and analyzed by HPLC as described above.
Electrospray Ion Mass Spectrometry. The major fractions from HPLC analysis that corresponded to the radiolabeled peaks were collected and analyzed by electrospray mass spectrometry using a VG/Fisons Platform single-quadrupole spectrometer (Beverly, MA). These analyses were performed at the University of Michigan Protein and Carbohydrate Structure Facility.
Metabolism of EE. Following incubation with 100 M [ 3 H]EE for 1 h in a 1-ml reaction mixture, the control (ϪNADPH) and inactivated (ϩNADPH) samples were extracted with 4 ml of CH 2 Cl 2 and dried under N 2 according to a method previously described (Guengerich, 1990a) . The metabolites were separated by HPLC on a Varian Microsorb-MV C 18 column (5 m, 4.6 ϫ 250 mm; Palo Alto, CA) with a solvent system consisting of solvent A (0.1% acetic acid in water) and solvent B (70% acetonitrile, 29.9% methanol, and 0.1% acetic acid) using linear gradients from 30% B to 50% B over 3 min, then to 60% B within the next 12 min, and then to 95% B for an additional 10 min at a flow rate of 1.2 ml/min, and the eluate was monitored at 280 nm. The retention times of the metabolites were compared with those of authentic standards. The major metabolite containing fractions (A-D) were collected, dried, derivatized, and analyzed by GC-MS at the Michigan State University Mass Spectrometry Facility. Each sample was incubated with 5 l of redistilled pyridine and 20 l of N, O-bis[trimethylsilyl] trifluoroacetamide containing 1% trimethylchlorosilane for 30 min at 70°C. Each sample was chromatographed on a 30-m DB1 fused silica capillary column (0.32 mm i.d., 0.25 m film coating; J&W Scientific, Folsom, CA) with a temperature gradient of 10°C per minute from 80 -320°C and analyzed over m/z range from 45 to 750 on a JEOL JMS AX-505 double focusing mass spectrometer (Tokyo, Japan) coupled to a Hewlett-Packard 5890J gas chromatograph (Palo Alto, CA) via a heated interface.
Results
Inactivation of 3A4 by EE. The time course for the inactivation of 3A4 by various concentrations of EE is shown in Fig. 1 . The loss of activity followed pseudo first order kinetics. Linear regression analysis of the time course data was used to determine the initial rate constants for inactivation (k obs ) at various concentrations of EE. From the doublereciprocal plot (inset) of the values for k obs and the concentration of EE, the k inact was determined to be 0.04 min Ϫ1 , the K I was 18 M, and the t 1/2 was 16 min.
Changes in Absolute and Reduced CO Difference Spectra of EE-Inactivated 3A4. When 3A4 was incubated with 50 M EE for 30 min, the enzymatic activity of the NADPH-treated samples decreased to 33 Ϯ 2% (n ϭ 7), the absorbance at 415 nm of the absolute spectrum decreased to 65 Ϯ 4% (n ϭ 5), and the reduced CO difference spectrum decreased to 30 Ϯ 8% (n ϭ 5) compared with the control samples incubated with EE in the absence of NADPH. Representative data for the changes in the absolute and reduced CO difference spectra are illustrated in Fig. 2, A and B, respectively. The loss of the spectrally detectable cytochrome P450 at 450 nm was accompanied by a concomitant loss of the heme spectrum at 415 nm in the EE-inactivated 3A4. The removal of free EE by extensive dialysis did not lead to a significant recovery of either the catalytic activity, the absolute or the reduced CO difference spectra of the inactivated 3A4 (data not shown). Thus, the inactivation of 3A4 by EE could not be reversed by dialysis.
Substrate Protection. Simultaneous incubation of P450 3A4 with 50 M EE in the presence of an 8-or 16-fold molar excess of testosterone over EE in the primary reaction mixture reduced the ability of EE to inactivate 3A4 in a time-and concentration-dependent manner (Fig. 3) . These results indicate that testosterone competes with EE for metabolism by 3A4 and thereby protects against inactivation.
Determination of the Partition Ratio. P450 3A4 was incubated with various concentrations of EE, and the inactivation was allowed to progress for 1 h until it was essentially complete. The percentage of activity remaining was plotted as a function of the molar ratio of EE to 3A4. The turnover number was estimated from the intercept of the linear regression line obtained from lower ratios of EE to 3A4 with the straight line derived from the higher ratios of EE to 3A4 as described previously (Silverman, 1996) . With this method, we estimated a partition ratio of ϳ50 as illustrated in Fig. 4 . A partition ratio of ϳ120 for EE has previously been reported in human liver microsomes (Guengerich, 1988) .
Stoichiometry of Binding. The amount of EE that covalently bound to the apoprotein was determined by preci- ]EE in the presence or absence of NADPH followed by extensively washing the protein pellets with 5% sulfuric acid in methanol. After subtracting the residual radioactivity of EE in the control samples from the inactivated samples, a stoichiometry of approximately 1.3 nmol of EE metabolite bound per nanomole of 3A4 inactivated was obtained.
SDS-PAGE Analysis. After incubating the 3A4 in the reconstituted system with 50 M radiolabeled EE, the proteins in the control (ϪNADPH) and inactivated (ϩNADPH) samples were separated by SDS-PAGE and then stained with Coomassie Blue. One set of gels was photographed (Fig. 5A ) and then the protein bands were excised and the radioactivity measured. After subtracting the radioactivity in the control samples from the inactivated samples, the relative radioactivities associated with the proteins in the inactivated samples were as follows: reductase ϭ ϳ8%, catalase ϭ ϳ1%, and P450 3A4 ϭ ϳ91%. The other set of gels was dried and analyzed by autoradiography. As shown on Fig. 5B, [ 3 H]EE was only observed in the NADPH-treated samples with the major amount of radioactivity associated with the 3A4 apoprotein and some radioactivity with reductase. These results demonstrate that the intensities of the protein components are similar in both the control and inactivated samples whereas the radioactivity derived from an EE reactive intermediate was predominantly associated with P450 3A4 in the inactivated sample. From the stoichiometry of binding, the autoradiography, and the radioactivity associated with the 3A4 apoprotein, we conclude that the EE reactive intermediate is covalently bound to the 3A4 apoprotein. The binding of a small amount of [ 3 H]EE to reductase may reflect the Portions of the samples were removed from the primary reaction mixture at the time points indicated and assayed for catalytic activity remaining. The molar ratios of substrates were no testosterone or EE (F), testosterone/EE ϭ 16:1 (E), testosterone/EE ϭ 8:1 (f), and EE only (Ⅺ).
Fig. 4.
Loss of P450 3A4 activity as a function of the ratio of EE to 3A4. P450 3A4 was incubated with various concentrations of EE for 1 h until the inactivation was essentially complete. The extrapolated partition ratio was estimated from the intercept of the linear regression line from the lower ratios and the straight line obtained from higher ratios.
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ability of some of the reactive intermediate escaping from the 3A4 active site. HPLC Analysis. After extensively dialyzing the reconstituted systems, which had been exposed to radiolabeled EE, HPLC was used to separate the heme moiety from the apoprotein under acidic conditions. The elution profiles monitored at 405 nm showed that the heme eluted at ϳ18 min for both the inactivated (ϩNADPH) and control (ϪNADPH) samples (Fig. 6A) . The area under the EE-inactivated 3A4 heme peak was 48 Ϯ 3% (n ϭ 7) compared with the control and a small peak of modified heme, which exhibited maximum absorbance at 400 nm with photodiode-array detector, was apparent at ϳ28 min in the inactivated sample. As shown in Fig. 6B , the reductase eluted at ϳ36 min, and the 3A4 apoprotein eluted at ϳ43 min. The elution profile monitored at 280 nm (Fig. 6B ) and 220 nm (data not shown) demonstrated that essentially all the reductase can be recovered from the column, whereas only 53 Ϯ 3% (n ϭ 7) of the 3A4 apoprotein in the NADPH-treated sample can be recovered compared with control samples. When the fractions were collected for liquid scintillation counting, several radiolabeled peaks were found in the NADPH-treated sample with no detectable radioactivity in the control sample (Fig. 6C) . Radiolabeled EE was associated with the 3A4 apoprotein in the inactivated sample. However, the largest radiolabeled fraction corresponded to the peak eluted at ϳ31 min (Peak 31). "Peak 31" and the other three small peaks at 24 to 27 min were also apparent in the elution profile of the NADPHtreated sample monitored at 280 nm but were not seen in the control sample (Fig. 6B) . HPLC analysis using a photodiodearray detector demonstrated that the absorption spectrum of Peak 31 exhibited a maximum at 280 nm (spectrum not shown). The lack of absorbance of Peak 31 around 400 nm indicates that this radiolabeled species is neither intact heme nor its tetrapyrrolic skeleton. Moreover, HPLC analysis of the trifluoroacetic acid/butanone extract revealed the presence of a major radiolabeled peak in the elution profile from the NADPH-treated sample, but not in the profile from the control sample (data not shown). These findings suggested that one or more radiolabeled products were formed from the reaction of metabolites of EE with heme fragments in the reconstituted system that were still associated with the protein after exhaustive dialysis and then could be dissociated from the apoprotein under acidic/organic conditions. Electrospray Ion Mass Spectrometry. The fraction corresponding to Peak 31 was collected and analyzed using an electrospray mass spectrometer in the negative-ion mode. As shown in Fig. 7 , there is one major peak with a mass (M Ϫ H) Ϫ of 479 Da from the fraction in the NADPH-treated sample. No such peak could be detected by electrospray mass spectrometry from the fraction, which eluted at ϳ31 min in the control sample (data not shown). The chemical structure of this EE-related modified species remains to be established.
Metabolite Analysis. In humans, the primary route for the metabolism of EE involves hydroxylation at the 2 position, but hydroxylation at the 4, 6, and 16 positions also occurs. There is also evidence for the oxidation of the ethynyl triple bond, deethylation and D-homoanulation (Bolt, 1979) . As shown in Fig. 8 , four distinct radiolabeled metabolites, peaks A, B, C, and D, were produced from the metabolism of EE (peak E) by 3A4 in the presence of NADPH. These four peaks were not observed in the HPLC elution profile of control samples (data not shown). The major metabolite (D) Fig. 5 . SDS-PAGE separation of 3A4 apoprotein reductase and catalase in the reconstituted system after incubation with radiolabeled EE in the absence (minus) or presence (ϩ) of NADPH. A, Coomassie Blue-stained gel. B, autoradiography of the dried gel. Fig. 6 . HPLC elution profiles of the reconstituted system after incubating with radiolabeled EE in the presence or absence of NADPH. A, chromatograms monitored at 405 nm for intact heme. B, chromatograms monitored at 280 nm for apoprotein and EE. C, corresponding HPLC elution profile monitored by liquid scintillation counting to determine the fractions containing covalently bound EE. Heme eluted at ϳ18 min, reductase at ϳ36 min, and 3A4 apoprotein at ϳ43 min.
eluted from the HPLC with the same retention time (18.5 min) as authentic 2-OH-EE standard. GC-MS analysis confirmed that D was 2-OH-EE since the GC retention time in the total ion chromatogram (TIC), the m/z of the molecular ion (528) as well as the m/z of the ion fragments were identical to those observed for the 2-OH-EE standard (data not shown).
Peak C Eluted Just Prior to 2-OH-EE with a Retention Time of 17.5 Min. GC-MS analysis showed that the retention time for C in the TIC was similar to but slightly later than 2-OH-EE. The m/z of C was 528, which is identical to that of 2-OH-EE. All the m/z ion fragments of C were also identical to 2-OH-EE with the exception of a fragment at 147 seen with 2-OH-EE but not in C, where a 153 ion was observed instead. From these results the most likely identity of C is either the 6-OH or the 4-OH product of EE. Studies on the metabolism of EE by human liver microsomes suggest that formation of 6-OH-EE is predominant over formation of 4-OH-EE (Purba et al., 1987) .
Peaks A and B eluted from the HPLC column at 13 and 17 min, respectively. GC-MS analysis indicated that both peaks contained a mixture of metabolites. However, the major metabolite in each peak had a m/z of 384 (peak A) or 456 (peak B) for the parent ions indicative of singly (peak A) or doubly (peak B) hydroxylated compounds with masses of 312 Da. The HPLC retention times as well as the GC-MS TIC retention times, parent masses, and the associated mass fragments did not correspond to any of the standards (2␣-, 4␣-, or 16␣-hydroxyestradiol, estrone, or the EE carboxylic acid) that were tested and could, therefore, not be identified.
Discussion
Enzymatic Activity. The results presented here demonstrate that EE is an effective mechanism-based inactivator of 3A4. The inactivation of the 6␤-testosterone hydroxylation of 3A4 was time-and concentration-dependent and required NADPH. The inactivation exhibited pseudo first order kinetics with a K I ϭ 18 M, a k inact ϭ 0.04 min Ϫ1 and a t 1/2 ϭ 16 min. In addition, the inactivation was irreversible by dialysis and the rate of inactivation decreased in the presence of the alternate substrate testosterone. Although the inclusion of cytochrome b 5 in the reconstituted mixture stimulated the rate of inactivation up to 2-fold, the residual activity of the inactivated samples was very close regardless of the presence or absence of b 5 (data not shown). Since the absolute spectrum of the b 5 heme shifted from 415 to 424 nm in the presence of reductase and the heme moieties of both b 5 and 3A4 coeluted in the HPLC analysis under acidic conditions, we eliminated b 5 from our studies on the mechanism of Covalent Binding of EE to 3A4 Apoprotein. Modification of the 3A4 apoprotein was demonstrated by the following: 1) SDS-PAGE separation of the proteins in the reconstituted system demonstrated that most of the counts from radiolabeled EE were associated with the 3A4 protein (Fig.  5B) ; 2) stoichiometry of 1.3 nmol of EE bound per nmol of 3A4 inactivated was determined; 3) HPLC analysis indicated that radiolabeled EE associated with the fraction corresponding to 3A4 apoprotein in the NADPH-treated sample (Fig. 6C , retention time at 43 min); and 4) the amount of heme loss detected in the UV-visible spectrum and HPLC analysis was much less than the loss of spectrally detectable P450, and the loss in catalytic activity indicated that heme modification alone was not responsible for all the EE-dependent inactivation. The inactivated 3A4 apoprotein was fully recovered during the SDS-PAGE separation (Fig. 5A ), whereas only ϳ53% was recovered by HPLC separation of the reconstituted system compared with the control sample (Fig. 6B) . Modification of 3A4 by cumene hydroperoxide, mifepristone, or bergamottin is believed to result in the exposure of hydrophobic groups on the P450 protein, so that it cannot elute from reversed-phase HPLC column (He et al., 1998a (He et al., ,b, 1999 . Taken together, our results suggest that the amount of radiolabeled EE associated with 3A4 apoprotein is underestimated from the reversed-phase HPLC analysis.
Heme Destruction and Formation of EE-Conjugated Compounds. Based on the loss of spectrally detectable P450, the formation of an N-substituted porphyrin was postulated to be involved in the inactivation of human P450s by EE (Guengerich, 1988) . We report here that 3A4 inactivation by EE results not only in the loss of the reduced CO difference spectrum at 450 nm, but also in the loss of the absolute spectral absorbance at 415 nm and the loss of intact heme, as determined by HPLC, with concomitant generation of several EE-radiolabeled species. The formation of a small fraction of modified heme adduct, observed in the NADPH-treated sample, was in agreement with the formation of green pigment in rat hepatocyte suspensions after incubation with EE (Blakey and White, 1986) . The EE-radiolabeled species are very stable and can be recovered even after dialysis at 4°C for 4 days. The major radiolabeled species, Peak 31, having a mass of 479 would appear to be an EE-alkylated heme fragment that does not irreversibly bind to 3A4 apoprotein based on the following observations: 1) the maximal absorbance at 280 nm rather than 400 nm suggests that the EE-mediated inactivation apparently ruptures the intact heme chromophore or that the EE-labeled heme has a short half-life and is degraded to heme fragments; 2) EE and heme fragments exhibit absorbance at 280 nm (Schaefer et al., 1985; Correia et al., 1987; Guengerich, 1988) ; 3) the difference in the mass of the Peak 31 (479 Da) and EE (296 Da) is consistent with a monopyrrole fragment; and 4) the EE-labeled moiety can be dissociated from the 3A4 apoprotein under organic/acidic conditions. Therefore, we conclude that reaction of the EE metabolites with prosthetic heme results in the formation of not only the modified heme, but also the destruction or degradation of the intact heme with concomitant generation of EE-modified heme fragment adducts. The chemical structure(s) and the nature of adduction of these modified species remain to be established.
Oxidation of Acetylenic Compounds. Studies by Ortiz de Montellano and coworkers on the inactivation of P450 by acetylenic compounds have led to the suggestion that the differential inactivation by modification of the prosthetic heme group versus the apoprotein depends primarily on the delivery of the ferryl oxygen to the internal carbon (heme alkylation) or to the external carbon (protein alkylation) of the acetylene moiety (Kunze et al., 1983; Komives and Ortiz de Montellano, 1987; Chan et al., 1993) . Phenylacetylene attacks the prosthetic heme in both P450 2B1 and P450 1A1, whereas 2-ethynylnaphthalene attacks the P450 2B1 apoprotein and 1-ethynylpyrene attacks the P450 1A1 apoprotein (Chan et al., 1993; Roberts et al., 1993; Ortiz de Montellano and Correia, 1995) . These results demonstrate that a single isozyme can be inactivated by alkylation of either the heme or the protein depending on the structure of the arylacetylene. The loss of catalytic activity and the formation of heme adducts in rabbit P450 2E1 modified by ethynyl compounds is much greater than in a mutant of P450 2E1 where threonine 303 was replaced with alanine (Roberts et al., 1998) . The studies reported here demonstrate that EE can modify both the heme and the apoprotein of P450 3A4, whereas EE only modified the apoprotein in P450 2B1 and P450 2B6 (Kent et al., 2002) . These results support the hypothesis that the metabolic activation of a single ethynyl compound can result in different reactivities toward heme versus apoprotein with different P450 isozymes.
Inactivation of 3A4. Three pathways for the mechanismbased inactivation of P450 isozymes have been characterized: 1) covalent modification of the apoprotein; 2) alkylation of the heme moiety; and 3) covalent binding of the modified heme to the apoprotein (Osawa and Pohl, 1989; Ortiz de Montellano and Correia, 1995) . Our results provide evidence for the occurrence of pathways 1 and 2 in the EE-mediated inactivation of 3A4. Using [ 3 H] and [ 14 C]heme-labeled P450, a wide variety of suicide substrates have been shown to inactivate P450 by the destruction of heme and covalent attachment of the modified heme to the apoprotein as demonstrated by the isolation of active site heme-modified peptides from P450s 2B1 and P450 3A4 (Guengerich, 1986; Correia et al., 1987; Osawa and Pohl, 1989; Yao et al., 1993; He et al., 1998a) . Ortiz de Montellano and Correia (1995) have proposed that the 3A4 active site is particularly susceptible to inactivation by heme-protein adduct formation. It should be pointed out that during the oxidation of norethindrone, an acetylenic steroid, by rat liver microsomes, a considerable portion of the heme is destroyed and is irreversibly attached to the P450 apoprotein (Davies et al., 1986 ). Since we were only able to recover half the 3A4 P450 in the inactivated samples, we cannot rule out the possibility that the cross-linked EEmodified heme or heme fragments were lost in the HPLC column.
We also attempted to identify the reactive EE intermediate(s) responsible for either protein or heme modification. Our metabolism studies conclusively identified the previously reported 2-OH product of EE as the major metabolite. However, with our HPLC separation method, we were also able to show that EE metabolism by 3A4 generated at least four metabolites. The major metabolite 2-OH-EE could be identified by GC-MS, and a second metabolite is most likely the 4-or 6-hydroxylated product of EE. The remaining two metabolites could not be conclusively identified primarily due to the lack of authentic standards. Further detailed analysis of the latter two metabolites was not possible since they were generated in very small amounts. Metabolites of EE with similar masses were observed previously. Schmid et al. (1983) have previously identified a 17-formyl-D-homosteroid that was formed from EE by hepatic microsomes of female rhesus monkeys. Recently, similar metabolites were also observed in studies with purified P450 enzymes of the 2B family (Kent et al., 2002 ). An attack on the terminal acetylenic carbon followed by the formation of a ketene intermediate has previously been proposed (Guengerich, 1990a) , and the mass of metabolite B would be consistent with the mass of this ketene intermediate. This intermediate would not be expected to be stable in aqueous solutions and would rearrange to the corresponding carboxylic acid. Previous observations with an authentic standard indicated that this EE carboxylic acid would elute under our HPLC conditions very close to the EE parent and, if generated in small amounts, would be very difficult to detect as a separate peak. However, GC-MS analysis would have revealed the carboxylic acid if the ketene intermediate had been formed during the EE metabolism by P450 3A4.
In summary, the EE-dependent inactivation of 3A4 exhibited a number of characteristics consistent with mechanismbased inactivation. In agreement with the studies reported for the oxidation of EE by human liver P450s, the EE-mediated inactivation of 3A4 was associated with some loss of prosthetic heme (Guengerich, 1988) . Furthermore, in this study, we provide evidence for the occurrence of covalent binding of a metabolite of EE to the apoprotein.
